| scholarly article | Q13442814 |
| P2093 | author name string | Yan Wu | |
| Xiaoyun Shen | |||
| Thomas R Kosten | |||
| Frank M Orson | |||
| Roger D Rossen | |||
| Angel Y Lopez | |||
| P2860 | cites work | Molecular and cellular signatures of human vaccine adjuvants. | Q30370898 |
| Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial | Q33883669 | ||
| Covalent modification of proteins by cocaine | Q34018269 | ||
| Levamisole in cocaine: unexpected news from an old acquaintance. | Q34031280 | ||
| T-independent type II immune responses generate memory B cells | Q36228283 | ||
| Addictive drugs and their relationship with infectious diseases | Q36548780 | ||
| The future of vaccines in the management of addictive disorders | Q36960183 | ||
| Substance abuse vaccines | Q36983386 | ||
| A distinct role for B1b lymphocytes in T cell-independent immunity | Q37032043 | ||
| Vaccine adjuvants: current challenges and future approaches. | Q37244036 | ||
| Cutting edge issues in Goodpasture's disease | Q37826115 | ||
| Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens | Q39034572 | ||
| Immunotherapy for prostate cancer enters its golden age. | Q39577914 | ||
| Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia | Q40032000 | ||
| Studies on B-cell memory. II. T-cell independent antigen can induce B-cell memory | Q41132256 | ||
| Getting closer to the dirty little secret | Q41761213 | ||
| Mechanisms of cocaine-induced decreases in immune cell function | Q43611487 | ||
| Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody | Q44706451 | ||
| Understanding thymus-independent antigen-induced reduction of thymus-dependent immune responses | Q44935596 | ||
| MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). | Q46102734 | ||
| Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. | Q46420019 | ||
| Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine | Q46659652 | ||
| The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody | Q47816295 | ||
| Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers | Q47860399 | ||
| Cocaine effects on immunocompetent cells: an observation of in vitro cocaine exposure. | Q51445536 | ||
| Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies | Q72079060 | ||
| The effect of dose in tolerance induction on the subsequent response to a cross-reactive antigen | Q72404103 | ||
| VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE | Q76969494 | ||
| Expression of cholera toxin B subunit in transgenic tomato plants | Q78529703 | ||
| P433 | issue | 2 | |
| P921 | main subject | cholera | Q12090 |
| antibody | Q79460 | ||
| P304 | page(s) | 169-174 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | American Journal on Addictions | Q15762371 |
| P1476 | title | Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine | |
| P478 | volume | 22 |
| Q34132788 | Can you vaccinate against substance abuse? |
| Q35232735 | Cholera toxin B: one subunit with many pharmaceutical applications |
| Q38207705 | Drugs currently in Phase II clinical trials for cocaine addiction |
| Q39519649 | Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse |
| Q34496665 | Is immunotherapy an opportunity for effective treatment of drug addiction? |
| Q33719424 | New directions in nicotine vaccine design and use. |
| Q37082158 | Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse |
| Q28833846 | Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines |
| Q34438529 | Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems |
| Q34132804 | The future potential for cocaine vaccines |
Search more.